​

Pancreatic cancer is one of the world’s deadliest cancers with a five-year survival rate still in the singledigits and the time has come again to join forces to improve diagnosis, treatment, and care for patientswith pancreatic cancer by sharing state-of-the-art knowledge in cell biology, early detection, and diagnosis, as well as treatment and palliative care of these patients. The ambition with the symposium is to gather members from different specialties involved in the treatment of pancreatic cancer such as pathology, molecular biology, radiology and clinical physiology, oncology, surgery, gastroenterology, endoscopy, and palliative care to stimulate a fruitful debate and networking across expert fields.

After a successful symposium in 2022, we decided that the second symposium should focus on recent progress across fields.

We are delighted that national and internationally recognized experts have accepted our invitation to come and share recent knowledge about pancreatic cancer.​